Table 2 Procedure-related variables and outcomes
Total (n = 512) | Elective (n = 378) | Non-elective (n = 134) | P-value | |
|---|---|---|---|---|
Procedural duration [min] | 46 (37–56) | 46 (37–55) | 46 (37–57) | 0.414 |
Procedural contrast agent [mL] | 79 (62–99) | 78 (64–98) | 80 (57–100) | 0.727 |
Balloon-expandable valve, n [%] | 223 (43.6) | 162 (42.9) | 61 (45.5) | 0.613 |
Self-expanding valve, n [%] | 289 (56.4) | 216 (57.1) | 73 (54.5) | 0.613 |
Time: admission to discharge [days] | 6 (5–9) | 6 (5–6) | 15 (11–23) | < 0.001 |
Time: procedure to discharge [days] | 5 (4–6) | 4 (4–5) | 7 (5–13) | < 0.001 |
Discharge to home, n [%] | 422 (82.4) | 356 (94.2) | 66 (49.3) | < 0.001 |
Discharge to rehabilitation, n [%] | 81 (15.8) | 18 (4.8) | 63 (47.0) | < 0.001 |
VARC-3 | ||||
New PPI, n [%] | 74 (14.5) | 47 (12.4) | 27 (20.1) | 0.029 |
New LBBB, n [%] | 88 (17.2) | 75 (19.8) | 13 (9.7) | 0.008 |
New RBBB, n [%] | 8 (1.6) | 7 (1.9) | 1 (0.7) | 0.375 |
Stroke with disability, n [%] | 4 (0.8) | 2 (0.5) | 2 (1.5) | 0.281 |
Type 3 (life-threatening) bleeding, n [%] | 29 (5.7) | 17 (4.5) | 12 (9.0) | 0.055 |
Myocardial infarction, n [%] | 0 (0) | 0 (0) | 0 (0) | - |
Conversion to open surgery, n [%] | 4 (0.8) | 2 (0.5) | 2 (1.5) | 0.281 |
AKIN stage 3/4, n [%] | 2 (0.4) | 0 (0) | 2 (1.5) | - |
Death at 30 days, n [%] | 9 (1.8) | 4 (1.1) | 5 (3.7) | 0.030* |
MACE at 30 days, n [%] | 13 (2.5) | 6 (1.6) | 7 (5.2) | 0.021* |
Death at 1 year, n [%] | 44 (8.6) | 19 (5.0) | 25 (18.7) | < 0.001* |